Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
20,638,746
Share change
+341,324
Total reported value
$396,981,826
Price per share
$19.24
Number of holders
104
Value change
+$6,676,577
Number of buys
44
Number of sells
48

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2017

As of 31 Dec 2017, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,638,746 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, FEDERATED INVESTORS INC /PA/, Invesco Ltd., STATE STREET CORP, TEACHERS ADVISORS, LLC, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, and Bank of New York Mellon Corp. This page lists 104 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.